American Pharmacists Association Honors Research on Expanded Role for Pharmacy Technicians pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.
Managing Editor
The first vaccine to prevent COVID-19 has been cleared for use in the United States. The Food and Drug Administration on Saturday granted emergency use authorization to Pfizer and BioNTech’s COVID-19 vaccine for use in individuals 16 years old and older. The first shipments began leaving facilities on Sunday.
The FDA’s decision was based on data from its Phase 3 clinical study, whose results were published last week in the New England Journal of Medicine and which saw a 95% vaccine efficacy rate. The two companies continue to gather additional data and prepare a biologics license application for full approval from the FDA in 2021.
GOP Majority Leader Mitch McConnell | J. Scott Applewhite/AP
WASHINGTON Kentucky Sen. Mitch McConnell’s ban on lawsuits through 2024 against firms that don’t protect workers and consumers from the coronavirus is even worse than advertised, the National Council on Occupational Safety and Health reports, and an inspection of the measure’s underlying text confirms.
The GOP Majority Leader’s bill is actually S4317, introduced July 27 by Sen. John Cornyn, R-Texas. McConnell is the top co-sponsor. It bans not just lawsuits involving company exposure of workers and customers to the virus, but coronavirus-related suits under most labor laws, too. The exceptions: Workers comp laws and the original National Labor Relations Act.
Share this article
Share this article
WASHINGTON, Dec. 11, 2020 /PRNewswire/ The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration s approval of the first Emergency use Authorization for the COVID-19 vaccine. We heartily welcome the decision by the US Food and Drug Administration (FDA) to authorize the emergency use of the first COVID-19 vaccine, following the recommendation of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). This is a historic moment in the nation s effort to end the pandemic. The pharmacy profession is ready to do its part as qualified, active participants in administering these vaccines in accordance with guidance issued by the FDA, CDC, HHS and state and local health departments, as well as increasing access for the American public to these important disease prevention tools.
NACDS and coalition members are urging Congress to ensure that CMS is able to establish a Jan. 1, 2022 deadline for EPCS compliance to help address opioid-abuse issues.